CASI PHARMACEUTICALS, INC. Defined Contribution Plan, Cost
CASI PHARMACEUTICALS, INC. reported Defined Contribution Plan, Cost of $4.20 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2023-04-26
- CASI PHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2019 was $1.78M, a 145.86% increase from fiscal 2018.
- CASI PHARMACEUTICALS, INC. defined contribution plan, cost for fiscal 2018 was $724.00K.
| Period end | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|
| 2022-12-31 | $4.20M 20-F · filed 2023-04-26 | |
| 2021-12-31 | $3.10M 20-F · filed 2023-04-26 | $3.14M 10-K · filed 2022-03-28 |
| 2020-12-31 | $1.50M 20-F · filed 2023-04-26 | $1.54M 10-K · filed 2021-03-30 |
| 2019-12-31 | $1.78M 10-K · filed 2021-03-30 | |
| 2018-12-31 | $724.00K 10-K · filed 2020-03-16 |